| TITRE |
Registre de la Leucémie Myéloïde Chronique (LMC) du GQR-LMC |
| PROTOCOLE ID |
Registre LMC |
| CLINICAL TRIAL.gov ID |
|
| TYPE(S) DE CANCER |
Leucémie myéloïde chronique (LMC) |
| PHASE |
Autres |
| TYPE D'ÉTUDE |
|
| INSTITUTION |
CHUM
1051 rue Sanguinet
(514) 890-8000
|
| VILLE |
Montréal
|
| INVESTIGATEUR(RICE) PRINCIPAL(E) |
Harold J. Olney
|
| COORDONATEUR(RICE) |
Julie Delbos
julie.delbos.chum@ssss.gouv.qc.ca
514-890-8000 poste 25385
|
| STATUT |
Actif en recrutement
|
| CRITÈRES D'ÉLIGIBILITÉ |
(EN) All patients in Canada who meet the following inclusion criteria may be enrolled in the CML
Registry:
- have a clinical diagnosis of CML;
- are 18 years of age or older;
- are able to give written, informed consent (or have a legal representative who can give written, informed consent when applicable).
|
| CRITÈRES D'EXCLUSION |
(EN) Patients who meet any of the following criteria will be excluded from participation:
- unwilling or unable to give written, informed consent;
- under 18 years of age;
- life expectancy of 3 months for a condition not related to CML
|
